RAPT
RAPT Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.29 / 10
Netural
Analyst sentiment is neutral, with six institutions all issuing 'Neutral' ratings in the past 20 days. Fund-flow analysis shows a good score of 7.63/10; small, medium, and large orders exhibit net inflows, while overall and block flows show mild outflows. This suggests institutional accumulation at lower sizes, supporting the bullish price action despite the neutral analyst consensus.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-20
InstitutionHC Wainwright & Co.
Times predicted4
Historical Win Rate75.0%
What is the analyst consensus for RAPT?
- RAPT holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.29/10 (Netural).
